Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

U.S. Sets Record for Worst Avian Flu Outbreak, With 50.5M+ Birds Dead

-Reuters Citing USDA

byCharles Gross

November 24, 2022

1 minute read

-Reuters Citing USDA

Legal
News

Syros Pharma US Patent & Trademark Office Abstract For Co.’s ‘Compositions of cyclin dependent kinase 7 (CDK7) inhibitor’

By Benzinga Newsdesk

Today, 10:49 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6686&f=G&l=50&d=PTXT&p=134&S1=20210810&OS=20210810&RS=20210810

SYRS

Citigroup Upgrades Thermo Fisher Scientific to Buy, Raises Price Target to $700

By Benzinga Newsdesk

Today, 10:49 AM

Citigroup analyst Patrick Donnelly upgrades Thermo Fisher Scientific (NYSE:TMO) from Neutral to Buy and raises the price target from $620 to $700.

TMO

GSK, Pfizer Backed Long-Acting HIV Med Under FDA Priority Review As Preventative Option

By Vandana Singh

Today, 10:49 AM

The FDA has accepted and granted Priority Review to ViiV Healthcare’s marketing application seeking approval for injectable cabotegravir long-acting for pre-exposure prophylaxis…

GILD

News

‘Apple Apparently Wants to Revive AirPower and Give It True Wireless Charging Abilities’ -Gizmodo Report

By Benzinga Newsdesk

Today, 10:49 AM

https://gizmodo.com/apple-apparently-wants-to-revive-airpower-and-give-it-t-1848130852?utm_source=twitter&utm_medium=SocialMarketing&utm_campaign=dlvrit&utm_content=gizmodo

AAPL

U.S. Sets Record for Worst Avian Flu Outbreak, With 50.5M+ Birds Dead

Related Posts

Syros Pharma US Patent & Trademark Office Abstract For Co.’s ‘Compositions of cyclin dependent kinase 7 (CDK7) inhibitor’

Citigroup Upgrades Thermo Fisher Scientific to Buy, Raises Price Target to $700

GSK, Pfizer Backed Long-Acting HIV Med Under FDA Priority Review As Preventative Option

‘Apple Apparently Wants to Revive AirPower and Give It True Wireless Charging Abilities’ -Gizmodo Report